Back to Business

Goldman Sachs downgrades Valneva stock rating to sell on Lyme vaccine uncertainty

Business April 22, 2026 at 5:45 AM

Goldman Sachs downgrades Valneva stock rating to sell on Lyme vaccine uncertainty

Investing.com

Read at Investing.com

More Stories

Bond Market Weathers Warsh Hawkish Hint: 3-Minutes MLIV

Bond Market Weathers Warsh Hawkish Hint: 3-Minutes MLIV

Guy Johnson, Tom Mackenzie and Paul Dobson break down today's key themes for analysts and investors on "Bloomberg: The O…

🇺🇸 Bloomberg Markets 15m ago

Rexel Q1 2026 slides: all regions return to growth after 11 quarters

Rexel Q1 2026 slides: all regions return to growth after 11 quarters

🇺🇸 Investing.com 15m ago

Ford to recall over 140,000 US vehicles over damaged wires

Ford to recall over 140,000 US vehicles over damaged wires

🇺🇸 Investing.com 15m ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play